Related Experiment Video
Updated: Apr 20, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
[Preventive effect of behavioral therapy plus flunarizine in children with migraine]
Yan-Zhao Chen1, Ning Li, Ke-Ying Zhou
1Department of Pediatrics, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, China. zhoukeying@163.com.
Insights
Behavioral therapy combined with flunarizine effectively reduced migraine symptoms in children. This combination therapy showed superior clinical efficacy compared to flunarizine alone for pediatric migraine prevention.
Area of Science:
- Pediatric neurology
- Clinical pharmacology
Context:
- Migraine is a common neurological disorder in children, significantly impacting their quality of life.
- Current treatment strategies for pediatric migraine often involve pharmacological and non-pharmacological approaches.
Purpose:
- To evaluate the preventive efficacy of behavioral therapy combined with flunarizine in pediatric migraine patients.
- To compare the effectiveness of combination therapy versus flunarizine monotherapy.
Summary:
- A randomized controlled trial involving 90 pediatric migraine patients compared behavioral therapy plus flunarizine against flunarizine alone over 3 months.
- The combination therapy group showed statistically significant improvements in the Pediatric Migraine Disability Assessment Score (PedMIDAS) and Bussone headache index compared to the control group.
Impact:
- Behavioral therapy plus flunarizine demonstrates enhanced clinical efficacy for preventing migraine in children.
- This combined therapeutic approach offers a promising strategy for managing pediatric migraine.
- Findings support the integration of behavioral interventions into pharmacological treatment plans for children with migraine.
Objective:
To investigate the preventive effect of behavioral therapy plus flunarizine in children with migraine.
Methods:
Ninety pediatric patients with migraine between January 2011and January 2014 were randomly divided into treatment group (45 cases) and control group (45 cases). The treatment group received behavioral therapy in addition to oral flunarizine, while the control group received oral flunarizine alone. All patients were followed up for 3 months to evaluate the therapeutic effect by the Pediatric Migraine Disability Assessment Score (PedMIDAS) and improved Bussone headache index.
Results:
There were no significant differences in PedMIDAS (P>0.05) and improved Bussone headache index (P>0.05) between the control and treatment groups before treatment. Significant differences were observed in PedMIDAS (16±8 vs 20±10; P<0.05) and improved Bussone headache index (25±18 vs 37±21; P<0.05) between the two groups after 3 months of treatment.
Conclusions:
Preventive treatment of behavioral therapy plus oral flunarizine shows a better clinical efficacy than oral flunarizine alone in children with migraine and holds promise for clinical application.
Related Concept Videos
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

